Compare DIOD & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIOD | AAPG |
|---|---|---|
| Founded | 1959 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 1995 | N/A |
| Metric | DIOD | AAPG |
|---|---|---|
| Price | $68.19 | $23.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $73.50 | $48.40 |
| AVG Volume (30 Days) | ★ 420.1K | 2.1K |
| Earning Date | 05-07-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.53 | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.51 | $388.23 |
| Revenue Next Year | $10.05 | N/A |
| P/E Ratio | $49.63 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.93 | $17.56 |
| 52 Week High | $81.71 | $48.45 |
| Indicator | DIOD | AAPG |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 48.13 |
| Support Level | $49.45 | $21.20 |
| Resistance Level | $72.31 | $25.23 |
| Average True Range (ATR) | 3.17 | 0.62 |
| MACD | 0.39 | -0.07 |
| Stochastic Oscillator | 52.13 | 59.92 |
Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.